Companies and Markets
Market Research A to Z | Company Profiles A to Z | Register | Contact Us
+44 (0) 203 086 8600 Call us on

Automated and Rapid Microbiological Tests: A Global Strategic Business Report

2673.38

Select License Type

Electronic License

Electronic License

An electronic version (mostly PDF, but can be Excel or PPT), which is either available for immediate download or will be sent via email by the Publisher of the report. The licencing for an electronic version is for use by the purchaser ONLY.

£2,673.38

Change Currency

GBP EURO USD

Market

Healthcare and Medical

Report Type

Market Research

Country

Global

Published

1 October 2011

Number of Pages

660

Report Delivery

Email

Delivery Lead Time

1-3 hours, 24 hour max

Publisher

Global Industry Analysts

File Format

-

Report: Evolutionary Battle Against Bugs to Drive Future Global Automated and Rapid Microbiological Tests Market

The automated and rapid microbiological tests market is expected to reach a global value of US$4.5 billion by 2017, and will be driven by a number of factors. These include the increasing prevalence of infectious diseases and sexually transmitted diseases, and increased technological research into faster, higher volume and more accurate methods of testing.

Automated and rapid microbiological tests have emerged into a core subdivision of applied microbiology. These tests have been largely gaining importance as a major area of research and application, for examining various kinds of microorganisms that are root cause of several diseases. With humans and bacteria locked in a perennial biological warfare, there exists a perpetual need for new and advanced rapid microbial testing methods and instruments. In addition, with fresh outbreaks of new diseases caused by ever changing and adapting mutating variants of bacteria, identifying pathogens in food, water, environment, and in the human body continues to gain importance. The ability to positively impact public health lies in quick, rapid and accurate identification of an infection and its causative bacterium. Learning to track, find, prevent and destroy these pathogens is a constant challenge confronting the medical community, which in turn ensures secure future for the automated and rapid microbiological tests market.

According to Global Industry Analysts, advancements in technology are leading to sweeping changes in the market for automated and rapid microbiological tests. Time constraints plaguing traditional testing methods are driving laboratories to opt for automated and rapid microbiological tests. Rapid tests allow for quantitative detection of pathogens in as short a time as 1-2 days, in contrast to conventional testing which takes 5-10 days. A vast majority of first-generation rapid tests are based on technologies such as immunoassays, chromatography and polymerase chain reactions, while second-generation rapid tests are engineered on advanced concepts of biotechnology and molecular diagnostics. The sheer number of rapid tests and their various technologies available in the market unnerves prospective buyers thereby making an appropriate purchase decision a hard task. Intimidated by the numerous high-flown technology related issues, buyers generally find themselves caught in a quagmire of environment-product-need fulfillment pros and cons that ultimately shape the system's ability to truly meet specific end-user requirements and needs.

The US continues to remain the largest regional market. Rapid microbiological tests market in the US is replete with strong market-focused players, with a broad portfolio of tests along with highly specialized offerings. Market saturation coupled with moderate price sensitivity is spawning an era of vertical and horizontal integration across the market, enabling companies to optimally target customers with broad-based, cost-efficient test services, given the low level of technology development. Advancements in molecular diagnosis such as the genetic probe tests hold the potential to cannibalize the market for traditional rapid microbiology tests.

Europe is expected to grow at a CAGR of about 5.6% over the analysis period. Rest of World market, comprising emerging economies of Asia Pacific and Latin America, offers significant growth opportunities in the automated microbiological test systems segment. With numerous laboratories continuing to grow in these regions, upgradation to automated instrumentation systems is expected to rank as the top priority in coming years. The market for Automated Identification and Susceptibility Systems is the largest end-use segment, while GC/Chlamydia Rapid Tests represents the fastest growing end-use segment with a CAGR of 5.3% over the review period.

Major players in the marketplace include Abbott Laboratories, Alere Inc., Becton Dickinson and Company, bioMerieux SA, Bio-Rad Laboratories Inc., Cellabs Pty Ltd, Celsis International Plc, Coris BioConcept, F. Hoffmann-La Roche Ltd., Gen-Probe Inc., Sekisui Diagnostics LLC, MedMira Inc., Meridian Biosciences Inc., Orasure Technologies Inc., Orion Diagnostica Oy, Quidel Corp., Siemens Healthcare Diagnostics Inc., and Thermo Fisher Scientific Inc.

The research report titled Automated and Rapid Microbiological Tests: A Global Strategic Business Report provides a comprehensive review of trends, issues, strategic industry activities, and profiles of major companies worldwide. The report provides market estimates and projections (US$ Million) for end-use segments Clinical Applications (Automated Identification & Susceptibility Systems; Automated Blood Culture Systems; Automated Tuberculosis Systems; Streptococcal Infection Rapid Tests; GC/Chlamydia Rapid Tests; and Other Automated & Rapid Microbiological Tests), and Non-Clinical Applications, across geographic markets such as the US, Europe (France, Germany, Italy, UK, Spain, Russia, and Rest of Europe), and Rest of World. Global Industry Analysts ©

Speak to an Advisor

Call us on
+44 (0) 203 086 8600

Select License Type

Electronic License

Electronic License

An electronic version (mostly PDF, but can be Excel or PPT), which is either available for immediate download or will be sent via email by the Publisher of the report. The licencing for an electronic version is for use by the purchaser ONLY.

£2,673.38

Change Currency

GBP EURO USD

Visitor Comments

All posts are pre-moderated and must obey the house rules.

Change Currency

GBP
USD

Use our research skills: Get free support

Free Research Support: Let us do the work for you and find information from public and private sources of information. Contact us now and we can save you time and money.......Free Research Support

eBrandPromote: Get your brands ranked highly online

eBrandPromote: Let us promote your brand online through article writing, press release distribution, social media and search engine marketing services. Click here to download our eBrandPromote brochure.

Accessibility
Close

Contrast settings

Text size settings